MK0859

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0859, covering 2015-02-27 to 2015-06-04. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) [Phase 1]